関連する実験動画
Updated: Jan 31, 2026

06:23
Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
Published on: May 23, 2021
5.4K
補体介在性溶血性尿毒症症候群の再考:病態生理、診断、治療に関する洞察の進化
Ruah Alyamany1, Ann M Moyer2, Maria Alice V Willrich2
1Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States.
Frontiers in immunology
|January 30, 2026
まとめ
補体介在性溶血性尿毒症症候群(CM-HUS)は、補体系の調節不全によって引き起こされます。遺伝的要因と自己抗体がその複雑さに寄与しますが、補体阻害薬は患者の転帰を改善します。
科学分野:
- 腎臓病学
- 免疫学
- 血液学
背景:
- 非定型溶血性尿毒症症候群(aHUS)は、まれな血栓性微小血管症です。
- 制御されない代替補体経路の活性化によって発生し、多くの場合「2つのヒット」メカニズムを介します。
- 貧血、血小板減少症、腎障害を特徴とします。
主な方法:
- 補体系の遺伝学と病態生理に焦点を当てた文献レビュー。
- 診断上の課題と新たなバイオマーカーの分析。
- 補体阻害薬による治療転帰の評価。
結論:
- CM-HUSは、その複雑な病因の深い理解を必要とする、不均一で補体駆動性の疾患です。
- リスク層別化には、生体外アッセイとバイオマーカーを用いた精密な診断が不可欠です。
- 標的補体阻害は、患者に改善された治療効果を提供します。
関連する概念動画
Complement System
10.5K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.5K
Complementation Tests
6.2K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.2K
Pneumonia II: Pathophysiology
2.9K
The pathophysiology of pneumonia involves the following steps:
2.9K
Pathophysiology of Diabetes
3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Hypertension II: Pathophysiology
937
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
937
Pathophysiology of Vomiting
3.0K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.0K

